🔎 Trials Near Me

Početna › Bolesti probavnog sustava › Tennessee

Kliničke studije za Bolesti probavnog sustava u državi Tennessee

6 studija za Bolesti probavnog sustava traži sudionike na lokacijama u državi Tennessee.

Gradovi u državi Tennessee

Službeni tekst studije (engleski)

Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

  • Vanderbilt University Medical Center, Nashville
U tijeku regrutacijaFaza 3
Od 18 do 90 godina · Oba spola · Ažurirano 29. ruj 2026. · NCT07197944

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

  • Henry-Joyce Cancer Clinic, Nashville
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 28. ruj 2026. · NCT07222800

Product Surveillance Registry

  • Germantown
  • Memphis
  • Nashville
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 18. ruj 2026. · NCT01524276

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

  • 89bio Clinical Study Site, Chattanooga
  • 89bio Clinical Study Site, Cordova
  • 89bio Clinical Study Site, Hermitage
  • i još 1
U tijeku regrutacijaFaza 3
Od 18 do 80 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06318169

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

  • 89bio Clinical Study Site, Cordova
  • 89bio Clinical Study Site, Hermitage
  • 89bio Clinical Study Site, Nashville
U tijeku regrutacijaFaza 3
Od 18 do 75 godina · Oba spola · Ažurirano 3. ruj 2026. · NCT06419374

Feasibility, Safety, and Potential Efficacy of Fecal Microbiota Transplantation (FMT) for Gastrointestinal Dysfunction in Children Following Hematopoietic Cell Transplant (HCT).

  • St. Jude Children's Research Hospital, Memphis
U tijeku regrutacijaFaza 1
Do 22 godina · Oba spola · Ažurirano 20. srp 2026. · NCT05664113

Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.